We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.48%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.62B
AUM Growth
-$84.4M
Cap. Flow
-$358M
Cap. Flow %
-9.89%
Top 10 Hldgs %
26.83%
Holding
5,773
New
537
Increased
1,570
Reduced
3,043
Closed
580

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$46.2M
2
MSFT icon
Microsoft
MSFT
+$46.2M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$40M
4
NVDA icon
NVIDIA
NVDA
+$27.6M
5
PLTR icon
Palantir
PLTR
+$27.6M

Sector Composition

Rank Sector Weight
1 Technology 17.33%
2 Financials 7.48%
3 Consumer Discretionary 6.48%
4 Healthcare 6.28%
5 Communication Services 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CETY icon
4526
Clean Energy Technologies
CETY
$10.9M
$3.29K ﹤0.01%
771
-45
-6% -$167
GENK icon
4527
GEN Restaurant Group
GENK
$11.3M
$3.28K ﹤0.01%
1,194
+106
+10% +$373
ECOR icon
4528
electroCore
ECOR
$81.8M
$3.27K ﹤0.01%
661
+489
+284% +$2.85K
AMOD
4529
Alpha Modus Holdings
AMOD
$21.7M
$3.26K ﹤0.01%
+68
New +$3.15K
TAIT
4530
DELISTED
Taitron Components
TAIT
$3.25K ﹤0.01%
1,311
+23
+2% +$53
ADN
4531
DELISTED
Advent Technologies
ADN
$3.23K ﹤0.01%
969
+514
+113% +$1.51K
ACCS
4532
ACCESS Newswire
ACCS
$20.4M
$3.22K ﹤0.01%
300
-76
-20% -$863
NGL icon
4533
NGL Energy Partners
NGL
$2.18B
$3.2K ﹤0.01%
533
+433
+433% +$2.18K
ENSC icon
4534
Ensysce Biosciences
ENSC
$6.65M
$3.19K ﹤0.01%
1,348
-21
-2% -$45
COCH icon
4535
Envoy Medical
COCH
$58.1M
$3.19K ﹤0.01%
4,111
+872
+27% +$1.18K
BOLD
4536
Boundless Bio
BOLD
$64.1M
$3.19K ﹤0.01%
2,593
-3,479
-57% -$4.01K
DIT icon
4537
AMCON Distributing
DIT
$3.19K ﹤0.01%
42
+21
+100% +$1.6K
RLMD icon
4538
Relmada Therapeutics
RLMD
$468M
$3.18K ﹤0.01%
1,581
-4,608
-74% -$4.42K
GBR icon
4539
New Concept Energy
GBR
$3.59M
$3.17K ﹤0.01%
3,157
-816
-21% -$810
CDIO icon
4540
Cardio Diagnostics
CDIO
$5.53M
$3.16K ﹤0.01%
788
+688
+688% +$2.72K
EDSA icon
4541
Edesa Biotech
EDSA
$52.5M
$3.16K ﹤0.01%
1,279
-1,064
-45% -$2.46K
SABS icon
4542
SAB Biotherapeutics
SABS
$341M
$3.14K ﹤0.01%
1,560
+834
+115% +$1.89K
SWAG icon
4543
Stran & Co
SWAG
$37.8M
$3.14K ﹤0.01%
1,889
-1,415
-43% -$2.27K
RANI icon
4544
Rani Therapeutics
RANI
$89.6M
$3.11K ﹤0.01%
6,224
-3,061
-33% -$1.59K
DGICB
4545
Donegal Group Class B
DGICB
$3.11K ﹤0.01%
194
-905
-82% -$13.9K
CHT icon
4546
Chunghwa Telecom
CHT
$32.9B
$3.1K ﹤0.01%
71
+23
+48% +$1.02K
LIMN
4547
Liminatus Pharma
LIMN
$7.61M
$3.09K ﹤0.01%
1,848
+1,340
+264% +$5.78K
PLG
4548
Platinum Group Metals
PLG
$196M
$3.08K ﹤0.01%
1,164
+590
+103% +$1.01K
USAR
4549
USA Rare Earth Inc
USAR
$4.68B
$3.08K ﹤0.01%
179
-1,989
-92% -$28.4K
OVID icon
4550
Ovid Therapeutics
OVID
$482M
$3.05K ﹤0.01%
2,344
-49,176
-95% -$42.6K

Similar funds

Tower Research Capital (TRC)'s Q3 2025 Portfolio in Review

As of Q3 2025, Tower Research Capital (TRC) held 5,773 positions worth $3.62B, down 2.3% from $3.71B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) withdrew a net $358M in Q3 2025, closing 580 positions and reducing 3,043 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $23.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in JPMorgan Ultra-Short Income ETF worth $30.6M.

  • Tower Research Capital (TRC)'s largest Q3 2025 buy was JPMorgan Ultra-Short Income ETF: 603,010 shares worth $30.6M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2025, an estimated $254M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2025 reduction was Apple, cutting an estimated $46.2M.
  • Tower Research Capital (TRC) fully exited Vanguard S&P 500 ETF in Q3 2025, selling an estimated $23.6M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $3.62B portfolio in Q3 2025.
  • Tower Research Capital (TRC) opened 537 new positions and closed 580 in Q3 2025.
  • Tower Research Capital (TRC)'s portfolio value fell 2.3% quarter-over-quarter to $3.62B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.